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Sir,
We present a case of an 81-year-old female presenting with one week worsening dyspnea on exertion

Figure 1. Electrocardiogram showing ST depression in the inferolateral leads and ST elevation in aVR and V1-2.

Downloaded from http://qjmed.oxfordjournals.org/ at Thomas Jefferson University, Scott Library on August 3, 2012

25. Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S.
Statins and the risk of lung, breast, and colorectal cancer in
the elderly. Circulation 2007; 115:27–33.

Correspondence

821

Figure 3. Catheterization demonstrating occlusion of the
distal right popliteal and anterior tibial arteries.

and a cold, discolored, numb foot for 2 days. The
patient denied chest pain but reported a history consistent with melanotic stools. Her hemoglobin was

found to be 3.5 in the emergency department.
Electrocardiogram showed 0.5–1.0 mm ST depression in leads II, III, aVF, V4-6 and ST elevation in
aVR and V1-2 (Figure 1). Echocardiogram demonstrated a dilated left ventricle with a severely
reduced ejection fraction but preserved basal contractile function (Figure 2A: end diastole and B: end
systole). Catheterization demonstrated no epicardial
coronary artery disease, but occlusion of the distal
right popliteal and anterior tibial arteries (Figure 3).
The patient was treated with heparin, aspirin,
beta-blocker and angiotensin converting enzyme
inhibitor. The patient eventually required amputation of her right lower extremity. Gastroenterological
workup revealed a colon adenocarcinoma
which was successfully resected. Follow-up echocardiogram 4 weeks later demonstrated normal
left ventricular ejection fraction (Figures 4A: end
diastole and 4B: end systole). The final diagnosis
was tako-tsubo cardiomyopathy, precipitated
by severe anemia, leading to distal thrombus
embolization. Haghi et al.1 reported in this journal
the incidence of left ventricular thrombus in the
setting of tako-tsubo cardiomyopathy to be 8%.
However, they reported no episodes of peripheral
embolization due to the left ventricular thrombus.
This case illustrates the potential complications
associated with thrombus formation found to
occur in a minority of tako-tsubo cardiomyopathy
cases.

Downloaded from http://qjmed.oxfordjournals.org/ at Thomas Jefferson University, Scott Library on August 3, 2012

Figure 2. Echocardiogram (apical four chamber view) demonstrating a dilated left ventricle with severely reduced ejection
fraction but preserved basal contractile function. A: end diastole and B: end systole.
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Profound hypokalaemia mimicking
acute myocardial infarction
Sir,
A 70-year-old female, recently diagnosed with
metastatic rectal carcinoma requiring a de-functioning colostomy, presented to her local emergency
department with chest pain in keeping with myocardial ischaemia. An initial electrocardiogram (ECG)
demonstrated lateral ST-segment elevation and she
was urgently transferred to the regional percutaneous coronary intervention (PCI) centre. On arrival
her pain had settled. Emergency coronary angiography revealed single vessel disease in the form of

a heavily calcified non-flow limiting stenosis in
the mid-portion of the right coronary artery.
Echocardiography demonstrated a lateral wall
motion abnormality with no evidence of malignant
invasion of the pericardium or a pericardial effusion.
Troponin I was raised at 1.9 mg/l confirming a myocardial infarction and routine biochemistry revealed
a plasma potassium concentration of 2.9 mmol/l, for
which she was commenced on an intravenous
potassium chloride infusion. The following day she
developed recurrent episodes of ventricular tachycardia (VT) and repeat ECG demonstrated gross
global ST-segment elevation (Figure 1). She was
immediately taken back to the catheterization
laboratory, but angiographic appearances were
unchanged from the previous day. Biochemistry
now revealed profound hypokalaemia (2.1 mmol/l)
despite replacement and hypocalcaemia (corrected
1.75 mmol/l). On further questioning she had
noticed greatly increased output from her stoma
over the previous week. Her rhythm stabilized and
the ECG changes resolved over 24 h following
aggressive intra-venous replacement of electrolytes
up to normal levels.
This lady initially presented with ischaemic chest
pain, lateral ECG changes and a correlating wall
motion
abnormality
on
echocardiography.
Coronary artery disease was confirmed at angiography, but there was no evidence of an acute flow
limiting lesion. Whether this was due to coronary
vasospasm secondary to electrolyte disturbance or
a self-resolving plaque rupture is unclear. Her deterioration the following day with the development of
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Figure 4. Echocardiogram (apical four chamber view) 4 weeks later demonstrating normal left ventricular ejection fraction.
A: end diastole and B: end systole.

